Ying Huai

777 total citations
24 papers, 538 citations indexed

About

Ying Huai is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Ying Huai has authored 24 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Ying Huai's work include Bone Metabolism and Diseases (11 papers), MicroRNA in disease regulation (5 papers) and RNA Research and Splicing (5 papers). Ying Huai is often cited by papers focused on Bone Metabolism and Diseases (11 papers), MicroRNA in disease regulation (5 papers) and RNA Research and Splicing (5 papers). Ying Huai collaborates with scholars based in China, United States and Egypt. Ying Huai's co-authors include Wenjuan Zhang, Zhiping Miao, Airong Qian, Yonghua Wang, Kai Dang, Shanfeng Jiang, Ye Tian, Yipu Zhao, Chu Chen and Zhihao Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Life Sciences.

In The Last Decade

Ying Huai

23 papers receiving 529 citations

Peers

Ying Huai

CAM

PHARM

ONCOL

Zijian Yan China

Zhengquan Huang China

Xueqing Hu China

Kehe Yu China

Chao Zhuang China

Ji‐Yoon Noh South Korea

Xiaoyun Pan China

Hong Luo China

Jiarui Yuan China

Zijian Yan China

Ying Huai

279 ×0.9

71 ×0.9

34 ×0.4

CAM

47 ×0.7

PHARM

58 ×1.1

ONCOL

Citations per year, relative to Ying Huai Ying Huai (= 1×) peers Zijian Yan

Countries citing papers authored by Ying Huai

Since Specialization

Citations

This map shows the geographic impact of Ying Huai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Huai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Huai more than expected).

Fields of papers citing papers by Ying Huai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Huai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Huai. The network helps show where Ying Huai may publish in the future.

Co-authorship network of co-authors of Ying Huai

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Huai. A scholar is included among the top collaborators of Ying Huai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Huai. Ying Huai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Chaofei, Ying Huai, Xingcong Ma, et al.. (2025). Bio-engineered microRNA-7 effectively interferes with the Akt3/p53 axis to suppress human non-small cell lung cancer. Cancer Cell International. 25(1). 250–250.

Huai, Ying, Xue Wang, Xuehao Wang, et al.. (2024). HuR‐positive stress granules: Potential targets for age‐related osteoporosis. Aging Cell. 23(3). e14053–e14053. 6 indexed citations

Yan, Jian, et al.. (2024). Proteome-wide Mendelian randomization provides novel insights into the pathogenesis and druggable targets of osteoporosis. Frontiers in Medicine. 11. 1426261–1426261. 1 indexed citations

Li, Hui, et al.. (2023). MiR-12200-5p Targets Multiple Members of Wnt Signaling Pathway toInhibit Osteoblast Differentiation and Bone Formation. Endocrine Metabolic & Immune Disorders - Drug Targets. 23(10). 1254–1264. 5 indexed citations

Jiang, Shanfeng, Chong Yin, Kai Dang, et al.. (2022). Comprehensive ceRNA network for MACF1 regulates osteoblast proliferation. BMC Genomics. 23(1). 695–695. 3 indexed citations

Huai, Ying, Zhihao Chen, Xue Wang, et al.. (2022). An integrated genome-wide analysis identifies HUR/ELAVL1 as a positive regulator of osteogenesis through enhancing the β-catenin signaling activity. Genes & Diseases. 10(2). 377–380. 4 indexed citations

Wang, Hong, Fan Li, Shuo Gao, et al.. (2022). Formononetin ameliorates simulated microgravity-induced bone loss by suppressing bone turnover in rats. Acta Astronautica. 200. 77–85. 6 indexed citations

Gao, Shuo, Ying Huai, Jiaqi Zhang, et al.. (2022). Calycosin prevents bone loss induced by hindlimb unloading. npj Microgravity. 8(1). 23–23. 9 indexed citations

Chen, Zhihao, et al.. (2022). Liquid–Liquid Phase Separation of Biomacromolecules and Its Roles in Metabolic Diseases. Cells. 11(19). 3023–3023. 26 indexed citations

10.

Zhao, Yipu, Ye Tian, Weiliang Ye, et al.. (2022). A lipid–polymer hybrid nanoparticle (LPN)-loaded dissolving microneedle patch for promoting hair regrowth by transdermal miR-218 delivery. Biomaterials Science. 11(1). 140–152. 27 indexed citations

11.

Huai, Ying, Xuehao Wang, Xiao Lin, et al.. (2022). How do RNA binding proteins trigger liquid-liquid phase separation in human health and diseases?. BioScience Trends. 16(6). 389–404. 11 indexed citations

12.

Huai, Ying, Wenjuan Zhang, Wei Wang, et al.. (2021). Systems pharmacology dissection of action mechanisms for herbs in osteoporosis treatment. Chinese Herbal Medicines. 13(3). 313–331. 6 indexed citations

13.

Ma, Xiaoli, Ye Tian, Ying Huai, et al.. (2021). Kaempferide enhances antioxidant capacity to promote osteogenesis through FoxO1/β-catenin signaling pathway. European Journal of Pharmacology. 911. 174555–174555. 11 indexed citations

14.

Chen, Zhihao, Yan Zhang, Fan Zhao, et al.. (2021). miR-138–5p negatively regulates osteoblast differentiation through inhibiting β-catenin under simulated microgravity in MC3T3-E1 cells. Acta Astronautica. 182. 240–250. 9 indexed citations

15.

Zhang, Wenjuan, Kai Dang, Ying Huai, & Airong Qian. (2020). Osteoimmunology: The Regulatory Roles of T Lymphocytes in Osteoporosis. Frontiers in Endocrinology. 11. 465–465. 61 indexed citations

16.

Huai, Ying, Wenjuan Zhang, Zhihao Chen, et al.. (2020). A Comprehensive Analysis of MicroRNAs in Human Osteoporosis. Frontiers in Endocrinology. 11. 516213–516213. 20 indexed citations

17.

Zhang, Wenjuan, et al.. (2019). A Retrospective cohort study on the risk factors of deep vein thrombosis (DVT) for patients with traumatic fracture at Honghui Hospital. BMJ Open. 9(3). e024247–e024247. 35 indexed citations

18.

Zhang, Wenjuan, et al.. (2019). Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery. Frontiers in Pharmacology. 10. 743–743. 161 indexed citations

19.

Zhang, Wenjuan, Yongguang Gao, Ying Huai, et al.. (2019). Systems pharmacology dissection of action mechanisms of Dipsaci Radix for osteoporosis. Life Sciences. 235. 116820–116820. 43 indexed citations

20.

Li, Dijie, Ye Tian, Chong Yin, et al.. (2019). Silencing of lncRNA AK045490 Promotes Osteoblast Differentiation and Bone Formation via β-Catenin/TCF1/Runx2 Signaling Axis. International Journal of Molecular Sciences. 20(24). 6229–6229. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact